Ready to play
Ready to play
The FDA announced a voluntary recall of certain lots of Cetirizine hydrochloride tablets, commonly sold as Zyrtec, due to potential cross-contamination with ranitidine, which may cause severe allergic reactions like anaphylaxis. The recall affects four manufacturing lots distributed nationwide, with possible discoloration or red spots on the tablets. No adverse events have been reported so far.
Notice: This Is an AI-Generated Summary
Comments (0)